Opening Of Pilot Clinical Trial In Synovial Sarcoma

Adaptimmune announced today that it has opened a Pilot, open-label clinical trial in synovial sarcoma at the National Cancer Institute (NCI), Bethesda, Maryland, testing its enhanced T cell receptor T cell therapy. A second site is planned to open later this year at Washington University, St. Louis, Missouri. Adaptimmune is focused on the use of T cell therapy to treat cancer, with the body's own machinery - the T lymphocyte cell - being used to target and destroy cancerous cells...

Source: http://feedproxy.google.com/~r/mnt/healthnews/~3/aWUZtUp29YA/231744.php

nutrition weight loss